Results 81 to 90 of about 730 (96)
Some of the next articles are maybe not open access.

AYUSH digital initiatives: Harnessing the power of digital technology for India’s traditional medical systems

Journal of Ayurveda and Integrative Medicine, 2022
Manickam Ponnaiah   +1 more
exaly  

AYUSH- 64: A potential therapeutic agent in COVID-19

Journal of Ayurveda and Integrative Medicine, 2022
Ashok Kumar Panda, , N Srikanth
exaly  

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease

Journal of Ayurveda and Integrative Medicine, 2022
Manohar Gundeti   +2 more
exaly  

Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19

Journal of Ayurveda and Integrative Medicine, 2022
Shailendra Gurav   +2 more
exaly  

Analysis of AYUSH studies registered in clinical trials registry of India from 2009 to 2020

Journal of Ayurveda and Integrative Medicine, 2021
M S Shree Devi, P Sathiyarajeswaran
exaly  

Impact of AYUSH 64 as an adjunctive to standard of care in mild COVID 19 - An open-label randomized controlled pilot study

Journal of Ayurveda and Integrative Medicine, 2022
Kalpesh Panara   +2 more
exaly  

AYUSH (Indian System of Medicines) Therapeutics for COVID-19: A Living Systematic Review and Meta-Analysis (First Update)

Journal of Integrative and Complementary Medicine, 2023
Kalpesh Panara, Anup Thakar
exaly  

AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study

Journal of Ayurveda and Integrative Medicine, 2022
Shruti Khanduri   +2 more
exaly  

Home - About - Disclaimer - Privacy